Challenges and recent progress in oral drug delivery systems for biopharmaceuticals

B Homayun, X Lin, HJ Choi - Pharmaceutics, 2019 - mdpi.com
Routes of drug administration and the corresponding physicochemical characteristics of a
given route play significant roles in therapeutic efficacy and short term/long term biological …

Oral drug delivery platforms for biomedical applications

J Ouyang, Z Zhang, B Deng, J Liu, L Wang, H Liu… - Materials Today, 2023 - Elsevier
Oral administration is perhaps the most commonly used and acceptable route for drug
delivery to patients, mainly due to its non-invasiveness, simplicity, and versatility …

Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA

MR Warren, C Zhang, A Vedadghavami… - Biomaterials …, 2021 - pubs.rsc.org
Bovine milk-derived exosomes have recently emerged as a promising nano-vehicle for the
encapsulation and delivery of macromolecular biotherapeutics. Here we engineer high …

Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches

W Wang, Z Huang, Y Huang, X Zhang, J Huang… - Advanced Drug Delivery …, 2022 - Elsevier
Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …

Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery

JL Wang, MS Hanafy, H Xu, J Leal, Y Zhai… - International Journal of …, 2021 - Elsevier
Lipid nanoparticles are increasingly used for drug and gene delivery, including the delivery
of small interfering RNA (siRNA). Pulmonary delivery of drug molecules carried by lipid …

Avoiding a sticky situation: bypassing the mucus barrier for improved local drug delivery

HC Zierden, A Josyula, RL Shapiro, HT Hsueh… - Trends in molecular …, 2021 - cell.com
The efficacy of drugs administered by traditional routes is limited by numerous biological
barriers that preclude reaching the intended site of action. Further, full body systemic …

Nanomedicine approaches for the pulmonary treatment of cystic fibrosis

C Velino, F Carella, A Adamiano… - … in Bioengineering and …, 2019 - frontiersin.org
Cystic fibrosis (CF) is a genetic disease affecting today nearly 70,000 patients worldwide
and characterized by a hypersecretion of thick mucus difficult to clear arising from the …

Mucin glycans signal through the sensor kinase RetS to inhibit virulence-associated traits in Pseudomonas aeruginosa

BX Wang, KM Wheeler, KC Cady, S Lehoux… - Current Biology, 2021 - cell.com
Mucus is a densely populated ecological niche that coats all non-keratinized epithelia, and
plays a critical role in protecting the human body from infections. Although traditionally …

Macro-and microrheological properties of mucus surrogates in comparison to native intestinal and pulmonary mucus

BC Huck, O Hartwig, A Biehl, K Schwarzkopf… - …, 2019 - ACS Publications
Mucus is a complex hydrogel that acts as a protective barrier in various parts of the human
body. Both composition and structural properties play a crucial role in maintaining barrier …

Oral drug delivery: conventional to long acting new-age designs

U Bhutani, T Basu, S Majumdar - European Journal of Pharmaceutics and …, 2021 - Elsevier
The Oral route of administration forms the heartwood of the ever-growing tree of drug
delivery technology. It is one of the most preferred dosage forms among patients and …